title: Personalized medicine and genomics: challenges and opportunities in assessing effectiveness, cost-effectiveness, and future research priorities.
abstract: Personalized medicine is health care that tailors interventions to individual variation in risk and treatment response. Although medicine has long strived to achieve this goal, advances in genomics promise to facilitate this process. Relevant to present-day practice is the use of genomic information to classify individuals according to disease susceptibility or expected responsiveness to a pharmacologic treatment and to provide targeted interventions. A symposium at the annual meeting of the Society for Medical Decision Making on 23 October 2007 highlighted the challenges and opportunities posed in translating advances in molecular medicine into clinical practice. A panel of US experts in medical practice, regulatory policy, technology assessment, and the financing and organization of medical innovation was asked to discuss the current state of practice and research on personalized medicine as it relates to their own field. This article reports on the issues raised, discusses potential approaches to meet these challenges, and proposes directions for future work. The case of genetic testing to inform dosing with warfarin, an anticoagulant, is used to illustrate differing perspectives on evidence and decision making for personalized medicine.
authors.affiliation: Department of Pediatrics and Center for Health and the Social Sciences, University of Chicago, Chicago, Illinois, USA.
authors.forename: Rena
authors.initials: R
authors.lastname: Conti
authors.forename: David L
authors.initials: DL
authors.lastname: Veenstra
authors.forename: Katrina
authors.initials: K
authors.lastname: Armstrong
authors.forename: Lawrence J
authors.initials: LJ
authors.lastname: Lesko
authors.forename: Scott D
authors.initials: SD
authors.lastname: Grosse
mesh_terms: D000925:Anticoagulants / Q000191:economics / Q000627:therapeutic use; D003362:Cost-Benefit Analysis; D003657:Decision Making; D003695:Delivery of Health Care; D019317:Evidence-Based Medicine / Q000191:economics*; D005544:Forecasting; D036281:Genetic Research; D005820:Genetic Testing; D005826:Genetics, Medical; D015894:Genome, Human; D023281:Genomics / Q000191:economics*; D006801:Humans; D010597:Pharmacogenetics / Q000191:economics; D057285:Precision Medicine / Q000191:economics* / Q000639:trends; D012106:Research / Q000639:trends; D014859:Warfarin / Q000191:economics / Q000627:therapeutic use
chemical_list: D000925:Anticoagulants; D014859:Warfarin